Crescent Grove Advisors LLC Sells 499 Shares of CVS Health Co. (NYSE:CVS)

Crescent Grove Advisors LLC lowered its position in CVS Health Co. (NYSE:CVS) by 7.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,961 shares of the pharmacy operator’s stock after selling 499 shares during the quarter. Crescent Grove Advisors LLC’s holdings in CVS Health were worth $268,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Flagship Harbor Advisors LLC increased its holdings in CVS Health by 9.0% during the fourth quarter. Flagship Harbor Advisors LLC now owns 31,456 shares of the pharmacy operator’s stock valued at $1,412,000 after buying an additional 2,603 shares during the period. apricus wealth LLC boosted its position in CVS Health by 2.1% during the 4th quarter. apricus wealth LLC now owns 37,055 shares of the pharmacy operator’s stock valued at $1,663,000 after acquiring an additional 765 shares in the last quarter. Exchange Traded Concepts LLC raised its position in shares of CVS Health by 17.9% in the 4th quarter. Exchange Traded Concepts LLC now owns 17,514 shares of the pharmacy operator’s stock worth $786,000 after acquiring an additional 2,661 shares in the last quarter. CX Institutional lifted its stake in shares of CVS Health by 35.1% during the 4th quarter. CX Institutional now owns 100,787 shares of the pharmacy operator’s stock worth $4,524,000 after purchasing an additional 26,178 shares during the last quarter. Finally, Southland Equity Partners LLC boosted its position in CVS Health by 44.0% during the fourth quarter. Southland Equity Partners LLC now owns 4,985 shares of the pharmacy operator’s stock valued at $224,000 after purchasing an additional 1,523 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Trading Up 1.6 %

CVS Health stock opened at $54.71 on Monday. The firm has a market cap of $68.84 billion, a PE ratio of 13.88, a P/E/G ratio of 0.80 and a beta of 0.59. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $80.75. The stock’s 50 day simple moving average is $51.24 and its two-hundred day simple moving average is $56.21. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The company had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. During the same quarter in the previous year, the company earned $2.21 earnings per share. The firm’s revenue for the quarter was up 6.3% on a year-over-year basis. Analysts anticipate that CVS Health Co. will post 5.22 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Investors of record on Thursday, January 23rd will be issued a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.86%. The ex-dividend date is Thursday, January 23rd. CVS Health’s payout ratio is presently 67.51%.

Wall Street Analysts Forecast Growth

CVS has been the subject of a number of recent research reports. StockNews.com downgraded shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. Barclays decreased their target price on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research report on Thursday, November 7th. Piper Sandler cut their price target on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a report on Monday, November 25th. UBS Group upped their price objective on shares of CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a report on Thursday, November 7th. Finally, Mizuho lowered their target price on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. One analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and an average price target of $68.71.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.